{"id":182096,"date":"2025-06-17T00:27:09","date_gmt":"2025-06-17T00:27:09","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/182096\/"},"modified":"2025-06-17T00:27:09","modified_gmt":"2025-06-17T00:27:09","slug":"un-site-pour-produire-latome-plus-fort-contre-le-cancer-pres-de-nantes","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/182096\/","title":{"rendered":"Un site pour produire l\u2019atome plus fort contre le cancer pr\u00e8s de Nantes"},"content":{"rendered":"<p>Ce n\u2019est qu\u2019une \u00e9tape qu\u2019annonce Framatome, leader international dans le domaine de l\u2019\u00e9nergie nucl\u00e9aire, \u00e9galement engag\u00e9 dans\u00a0le secteur de la sant\u00e9, qui dans un communiqu\u00e9 se dit <strong>\u00ab\u00a0heureux d\u2019annoncer le choix du terrain pour l\u2019installation du site pilote de production d\u2019Astate-211\u00a0\u00bb.<\/strong><\/p>\n<p>Framatome et IBA, le leader mondial des technologies d\u2019acc\u00e9l\u00e9ration de particules, avaient annonc\u00e9, d\u00e8s 2023, leur projet de d\u00e9veloppement d\u2019un r\u00e9seau de cyclotrons, l\u2019Astate-211. Sous ce nom, un radio-isotope\u00a0qui \u00e9met des particules alpha tr\u00e8s destructrices, mais sur une courte distance, donc r\u00e9duisant les effets ind\u00e9sirables de l\u2019exposition nucl\u00e9aire.\u00a0Framatome proc\u00e8de \u00e0 l\u2019investissement financier, tandis qu\u2019IBA apporte des \u00e9quipements.<\/p>\n<p><a href=\"https:\/\/rennes.maville.com\/actu\/actudet_-medecine-nucleaire-un-deuxieme-cyclotron-contre-le-cancer-pour-arronax-a-saint-herblain-_53511-5604684_actu.Htm\" target=\"_blank\" rel=\"noopener\">Cette installation pilote sera construite \u00e0 proximit\u00e9 d\u2019Arronax<\/a>, groupement d\u2019int\u00e9r\u00eat public bas\u00e9 \u00e0 Saint-Herblain, centre de recherche qui collabore avec le CHU et l\u2019ICO, l\u2019Institut de canc\u00e9rologie de l\u2019ouest.\u00a0Framatome et IBA enclenchent donc <strong>\u00ab\u00a0une nouvelle \u00e9tape vers des solutions th\u00e9rapeutiques de pointe contre le cancer\u00a0\u00bb.<\/strong><\/p>\n<p>Le CHU de Nantes, la commune de Saint-Herblain, Nantes M\u00e9tropole et la R\u00e9gion Pays de la Loire, accompagnent cette implantation.\u00a0Ce site pilote servira de base au d\u00e9veloppement d\u2019un large r\u00e9seau de cyclotrons de derni\u00e8re g\u00e9n\u00e9ration acc\u00e9l\u00e9rant des particules alpha en Europe et aux \u00c9tats-Unis.<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Ce n\u2019est qu\u2019une \u00e9tape qu\u2019annonce Framatome, leader international dans le domaine de l\u2019\u00e9nergie nucl\u00e9aire, \u00e9galement engag\u00e9 dans\u00a0le secteur&hellip;\n","protected":false},"author":2,"featured_media":182097,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2818],"tags":[1111,11,31896,101,1777,674,7482,1011,27,766,12,2636,3762,31989,25,13269],"class_list":{"0":"post-182096","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nantes","8":"tag-actu","9":"tag-actualites","10":"tag-atome","11":"tag-cancer","12":"tag-eu","13":"tag-europe","14":"tag-fort","15":"tag-fr","16":"tag-france","17":"tag-nantes","18":"tag-news","19":"tag-pays-de-la-loire","20":"tag-pres","21":"tag-produire","22":"tag-republique-francaise","23":"tag-site"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114695874058709738","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/182096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=182096"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/182096\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/182097"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=182096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=182096"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=182096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}